Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sildenafil for Cardiovascular Effects in Diabetic Subjects
NCT00692237Phase 4Completed
- Sponsor
- Sapienza University of Rome
- Start
- Jan 2008
- Primary completion
- Sep 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of sildenafil in type 2 diabetes mellitus (T2DM), sponsored by Sapienza University of Rome. Started Jan 2008; status: completed.
02
Drugs
sildenafil
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00692237.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00692237.